Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).

Breast Cancer Res · 2019 · PMC6357474 · PMID 30704493

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

borderline significantP = 0.073so close (0.05 < p ≤ 0.1)

In the HR+/HER2- subgroup the results was borderline significant (HR 0.15, 95% CI 0.02–1.19; P = 0.073).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.